Login
$NUVB
$4.55 +$0.04 (0.89%) Close

Consolidated Balance Sheets

In millions of USD, except per-share amounts
Q2 FY2026
As of Jun 30, 2026
Q1 FY2026
As of Mar 31, 2026
Q4 FY2025
As of Dec 31, 2025
Q3 FY2025
As of Sep 30, 2025
Q2 FY2025
As of Jun 30, 2025
Q1 FY2025
As of Mar 31, 2025
Q4 FY2024
As of Dec 31, 2024
Q3 FY2024
As of Sep 30, 2024
Q2 FY2024
As of Jun 30, 2024
Q1 FY2024
As of Mar 31, 2024
Q4 FY2023
As of Dec 31, 2023
Q3 FY2023
As of Sep 30, 2023
Q2 FY2023
As of Jun 30, 2023
Q1 FY2023
As of Mar 31, 2023
Q4 FY2022
As of Dec 31, 2022
Q3 FY2022
As of Sep 30, 2022
Q2 FY2022
As of Jun 30, 2022
Q1 FY2022
As of Mar 31, 2022
Q4 FY2021
As of Dec 31, 2021
Q3 FY2021
As of Sep 30, 2021
Assets
Current assets:
Cash and cash equivalents
Accounts receivable, net of allowance for credit loss of $nil and $nil
Inventory
Prepaid expenses and other current assets
Marketable securities
Interest receivable on marketable securities
Total current assets
Property and equipment, net of accumulated depreciation of $1,331 and $1,184, respectively
Intangible assets, net of accumulated amortization of $2,777 and $1,856, respectively
Lease security deposit
Operating lease right-of-use assets
Other non-current assets
Total assets
Liabilities and stockholders' equity
Current liabilities:
Accounts payable
Current operating lease liabilities
Contract liabilities, current portion
Liability related to revenue interest financing agreement, current portion
Short-term borrowings
Warrant liability
Contract liabilities, net of current portion
Accrued expenses
Total current liabilities
Contract liabilities, net of current portion
Non-current operating lease liabilities
Non-current liability related to revenue interest financing agreement, net of deferred financing costs of $3,818 and $4,241, respectively
Long-term borrowings, net of deferred financing costs of $3,042
Convertible debt, net of deferred financing costs of $7,376
Total liabilities
Class A convertible preferred stock, $.0001 par value per share; 851,202 shares issued and outstanding as of June 30, 2024.
Stockholders' equity
Class A and Class B common stock and additional paid in capital, $0.0001 par value per share; 1,060,000,000 (Class A 1,000,000,000, Class B 60,000,000 shares authorized as of June 30, 2026 and December 31, 2025 respectively 349,822,479 (Class A 348,822,479, Class B 1,000,000) and 346,503,675 (Class A 345,503,675, Class B 1,00,000) shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively.
Accumulated deficit
Accumulated other comprehensive loss
Total stockholders' equity
Total liabilities and stockholders' equity

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support